YOUR
Search

    22.05.2025

    ADVANT Merger Control: A Q&A on the regimes in the EU, France, Germany and Italy


    Merger control can be a substantial challenge whenbuying or selling companies or establishing joint ventures,especially for strategic and time-sensitive projects. This guide shall help companies in understanding the merger control filing requirements and navigating the merger control procedures in the EU, France, Germany and Italy. This is all the more important since the respective authorities – the European Commission (EU), the Autorité de la Concurrence (France), the Bundeskartellamt (Germany) and the Autorità Garante della Concorrenza e del Mercato (Italy) – are among the world’s most recognized and active merger control regulators. Combined, they reviewed more than 1,600 merger control notifications in 2024 (Germany approx. 900, EU 392, France 295 and Italy 102). 

    While these Q&A answer many typical questions that businesses may have, they naturally cannot be exhaustive. You are invited to contact our experts at any time should you have any additional or clarifying questions. Our experts serve as trusted competition counsel to major industry players in many key sectors, and represent clients before the European Commission and national competition authorities. In the past year alone, we have successfully advised on numerous complex deals, and obtained unconditional clearances in the vast majority of cases. In doing so, we have often worked in close cooperation with our M&A team and have provided comprehensive regulatory advice, including on foreign direct investment
    control and foreign subsidies regulation.

    We advise clients on all aspects of merger control law – both at Europe-wide level and within national jurisdictions – to enable them to achieve their business goals while limiting exposure to merger control risks. We analyze filing requirements, conduct feasibility studies, conceive filing strategies and analyze risks for transactions falling in the new category of transactions below controlling thresholds. We then represent clients in merger control proceedings in the EU, France, Germany and Italy, and coordinate their foreign merger control filings. If unavoidable, we support our clients when negotiating remedies and when appealing adverse decisions. Finally, we regularly help third parties in dealing with information requests and intervening against their competitors’ acquisitions.

    ADVANT Advises Pidigi S.p.A. on the Acquisition of Key Assets of Sympatex Technologies GmbH from Insolvency Proceedings
    Munich, 5 May 2026 – ADVANT Beiten has assisted the Italian firm Pidigi S.p.A.…
    Read more
    Start of first biologics rebate agreements: ADVANT Beiten advises spectrumK
    Berlin, 4 June 2026 - Effective 1 June 2026, spectrumK's first exclusive…
    Read more
    New Chinese Outbound Investment Regulations: Opportunities Through Compliance for Chinese Investors in Germany
    On June 1, 2026, Chinese Premier Li Qiang signed the State Council Order…
    Read more
    The EU's Foreign Subsidies Regulation and the Chinese "Blocking" Response: Navigating the Escalating Tensions Between Brussels and Beijing
    Introduction: A New Era of Legal Confrontation in EU-China Trade Relations The…
    Read more
    New Law: Directive on Repair of Goods Also Applies to Importers!
    Importers should be aware that consumers will have a right to have defective…
    Read more
    ADVANT Beiten Advises DGQ in Connection with Montagu Becoming a Majority Shareholder in DQS
    Frankfurt, 7 May 2026 – The international commercial law firm ADVANT Beiten has…
    Read more
    The EU-Mercosur Agreement as of May 1, 2026: Tariff Benefits and New Requirements for Businesses
    With the trade policy chapter of the EU-Mercosur Agreement entering into force…
    Read more
    China's New Counter-Sanctions Rules: Growing Risks for Global Companies
    China's new counter-sanctions regulations (Regulations No. 834 and 835)…
    Read more
    ADVANT Beiten Advises Klinikum Ernst von Bergmann on the Splitting of Klinikum Westbrandenburg GmbH into Two Sites
    Berlin, 13 April 2026 – The international commercial law firm ADVANT Beiten has…
    Read more